Orbit Discovery

About:

Orbit Discovery is a peptide display company identifying potential peptide drugs for a range of chronic diseases.

Website: http://www.orbitdiscovery.com/

Top Investors: Oxford Science Enterprises, Innovate UK, Future Planet Capital, Oxford Technology Management, Borealis Ventures

Description:

Orbit Discovery is a peptide display company identifying potential peptide drugs for a range of chronic diseases. Peptides offer the potential to make drugs with the specificity and efficacy of large biologic molecules combined with the smaller dose size, simpler routes of delivery and lower cost of manufacturing found with small molecules. They are, therefore, uniquely suited to the treatment of chronic diseases which impact large patient populations. Their technology supports all of the improvements that can be made to peptides which make them better drugs whilst simplifying the discovery process and accelerating drug development

Total Funding Amount:

12.6M GBP

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Oxford, Oxfordshire, United Kingdom

Founded Date:

2015-01-01

Contact Email:

info(AT)orbitdiscovery.com

Founders:

Graham Ogg, Terry Rabbitts

Number of Employees:

11-50

Last Funding Date:

2021-07-20

IPO Status:

Private

Industries:

© 2025 bioDAO.ai